- Stocks
- Healthcare
- NASDAQ: FBIO

Price (delayed)

$3.5

Market cap

$340.62M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.37

Enterprise value

$136.42M

The company's equity has surged by 184% YoY and by 6% QoQ

FBIO's quick ratio has soared by 76% YoY and by 9% QoQ

FBIO's revenue is down by 2.9% since the previous quarter but it is up by 2.8% year-on-year

FBIO's gross margin is down by 6% YoY

The gross profit has declined by 4.6% since the previous quarter and by 3.4% year-on-year

What are the main financial stats of FBIO

Market
Valuations
Earnings

Shares outstanding

97.32M

Market cap

$340.62M

Enterprise value

$136.42M

Price to earnings (P/E)

N/A

Price to book (P/B)

3.14

Price to sales (P/S)

6.39

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

3.08

Revenue

$44.27M

EBIT

-$28.45M

EBITDA

-$24.46M

Free cash flow

-$86.54M

Per share
Balance sheet
Liquidity

EPS

-$1.37

Free cash flow per share

-$1.07

Book value per share

$1.12

Revenue per share

$0.55

TBVPS

$4.66

Total assets

$391.04M

Total liabilities

$146.82M

Debt

$87.35M

Equity

$105.9M

Working capital

$264.17M

Debt to equity

0.82

Current ratio

5.91

Quick ratio

5.79

Net debt/EBITDA

8.35

Margins
Efficiency
Dividend

EBITDA margin

-55.3%

Gross margin

66.8%

Net margin

-97.1%

Operating margin

-232.1%

Return on assets

-13.4%

Return on equity

-47.3%

Return on invested capital

-24.8%

Return on capital employed

-8.4%

Return on sales

-64.3%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Fortress Biotech stock price performed over time

Intraday

-2.78%

1 week

-22.05%

1 month

-6.67%

1 year

25.45%

YTD

10.41%

QTD

-0.85%

How have Fortress Biotech's revenue and profit performed over time

Revenue

$44.27M

Gross profit

$29.58M

Operating income

-$102.76M

Net income

-$42.98M

Gross margin

66.8%

Net margin

-97.1%

The net margin has increased by 22% YoY and by 4.8% QoQ

FBIO's net income is up by 20% YoY and by 8% QoQ

FBIO's operating margin is down by 12% since the previous quarter

FBIO's operating income is down by 9% from the previous quarter and by 3% YoY

What is Fortress Biotech's growth rate over time

What is Fortress Biotech stock price valuation

P/E

N/A

P/B

3.14

P/S

6.39

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

3.08

Fortress Biotech's EPS has increased by 28% YoY and by 4.2% QoQ

The company's equity has surged by 184% YoY and by 6% QoQ

The P/B is 38% less than the 5-year quarterly average of 5.1 and 8% less than the last 4 quarters average of 3.4

The P/S is 12% above the last 4 quarters average of 5.7 but 11% below the 5-year quarterly average of 7.2

FBIO's revenue is down by 2.9% since the previous quarter but it is up by 2.8% year-on-year

How efficient is Fortress Biotech business performance

The company's return on equity has surged by 73% YoY and by 25% QoQ

The ROA has grown by 44% year-on-year and by 19% since the previous quarter

Fortress Biotech's return on sales has increased by 33% YoY and by 6% QoQ

FBIO's return on invested capital is up by 21% year-on-year and by 6% since the previous quarter

What is FBIO's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for FBIO.

How did Fortress Biotech financials performed over time

The total assets is 166% more than the total liabilities

Fortress Biotech's current ratio has soared by 93% YoY and by 8% from the previous quarter

FBIO's quick ratio has soared by 76% YoY and by 9% QoQ

The debt is 18% lower than the equity

The company's equity has surged by 184% YoY and by 6% QoQ

The debt to equity has dropped by 72% year-on-year and by 8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.